Moderna engages in the research, development, and manufacturing of prescription drugs for infectious diseases and other conditions. Its products and candidate pipelines are entirely based on its messenger RNA (mRNA) technology platform. The business covers preclinical molecular design, advancement of human clinical trials, and scaled production of vaccines. The company primarily supplies approved biological products and related vaccines to national governments and healthcare institutions.